Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF ‐κB activation and recurrent dexamethasone administration fails to suppress it in vivo

The Prostate, EarlyView.

Source: The Prostate - September 28, 2018 Category: Urology & Nephrology Authors: Sumeet Jain, Pujarini Dash, Aliva P. Minz, Sanghamitra Satpathi, Ajit G. Samal, Prativa K. Behera, Partha S. Satpathi, Shantibhusan Senapati Source Type: research